entertainment -WSS

entertainment

author：explore 2025-09-29 12:30:24 - browse：3

gantenerumab Alzheimer's disease Roche — Sebastien Bozon/AFP via Getty Images

Roche said Monday it was buying Telavant Holdings for $7.1 billion upfront, picking up a promising experimental therapy for inflammatory bowel diseases.

Telavant is owned by Roivant Sciences, with Pfizer holding a minority stake. The deal will allow Roche to develop the therapy, called RVT-3101, and, pending approval, sell it in the United States and Japan. Pfizer holds the commercial rights in other parts of the world.

The “Roi” in Roivant stands for “return on investment” and with this deal, the biotech, founded by Republican presidential candidate Vivek Ramaswamy but now run by CEO Matt Gline, certainly delivered. Last December, it essentially acquired RVT-3101 from Pfizer for $45 million and a commitment to invest in the drug’s development. Less than a year later, Roivant flipped the drug to Roche for at least $7.1 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Cancer cells are shown to suck energy source from immune cells

leisure time

WSS

Medicare wants to send $9 billion to 340B hospitals

US sending controversial cluster munitions to Ukraine until other ammo is ready: Kirby

There’s no way to know how good AI health technologies are

Swim instructor mom warns parents not to buy blue swimsuits for kids

Bank of America ordered to pay more than $100 million for double charging fees, withholding rewards

Bank of America ordered to pay more than $100 million for double charging fees, withholding rewards

knowledge

entertainment

hotspot

How one medical school became remarkably diverse

Takeaways from AdvaMed, the largest medical devices conference

In age of alternative facts, a scholarly course on calling out crap

A revolution in caring for preterm infants

Virginia high school admissions case could be legal follow

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

Walensky prepares to leave CDC — and Congress — behind

Akero's treatment for NASH falls short in cirrhosis study

Medical leaders decry Supreme Court decision on affirmative action

Biden declares emergency in flood

leisure time

Better Therapeutics data on benefit with GLP

Eight reasons why you should get an updated Covid vaccine

Eight reasons why you should get an updated Covid vaccine

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

Nevada Republican Sam Brown launching another Senate bid, teeing up marquee race

Humana CEO Bruce Broussard to step down in 2024

leisure time

entertainment

leisure time

focus